Literature DB >> 35392229

Preoperative Prediction of Microvascular Invasion Risk Grades in Hepatocellular Carcinoma Based on Tumor and Peritumor Dual-Region Radiomics Signatures.

Fang Hu1,2, Yuhan Zhang1, Man Li3, Chen Liu1, Handan Zhang1, Xiaoming Li1, Sanyuan Liu3, Xiaofei Hu1, Jian Wang1.   

Abstract

Objective: To predict preoperative microvascular invasion (MVI) risk grade by analyzing the radiomics signatures of tumors and peritumors on enhanced magnetic resonance imaging (MRI) images of hepatocellular carcinoma (HCC).
Methods: A total of 501 HCC patients (training cohort n = 402, testing cohort n = 99) who underwent preoperative Gd-EOB-DTPA-enhanced MRI and curative liver resection within a month were studied retrospectively. Radiomics signatures were selected using the least absolute shrinkage and selection operator (Lasso) algorithm. Unimodal radiomics models based on tumors and peritumors (10mm or 20mm) were established using the Logistic algorithm, using plain T1WI, arterial phase (AP), portal venous phase (PVP), and hepatobiliary phase (HBP) images. Multimodal radiomics models based on different regions of interest (ROIs) were established using a combinatorial modeling approach. Moreover, we merged radiomics signatures and clinico-radiological features to build unimodal and multimodal clinical radiomics models.
Results: In the testing cohort, the AUC of the dual-region (tumor & peritumor 20 mm)radiomics model and single-region (tumor) radiomics model were 0.741 vs 0.694, 0.733 vs 0.725, 0.667 vs 0.710, and 0.559 vs 0.677, respectively, according to AP, PVP, T1WI, and HBP images. The AUC of the final clinical radiomics model based on tumor and peritumoral 20mm incorporating radiomics features in AP&PVP&T1WI images for predicting MVI classification in the training and testing cohorts were 0.962 and 0.852, respectively.
Conclusion: The radiomics signatures of the dual regions for tumor and peritumor on AP and PVP images are of significance to predict MVI.
Copyright © 2022 Hu, Zhang, Li, Liu, Zhang, Li, Liu, Hu and Wang.

Entities:  

Keywords:  MRI; hepatocellular carcinoma; microvascular invasion; peritumor; radiomics

Year:  2022        PMID: 35392229      PMCID: PMC8981726          DOI: 10.3389/fonc.2022.853336

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  37 in total

1.  Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.

Authors:  Shi-Ting Feng; Yingmei Jia; Bing Liao; Bingsheng Huang; Qian Zhou; Xin Li; Kaikai Wei; Lili Chen; Bin Li; Wei Wang; Shuling Chen; Xiaofang He; Haibo Wang; Sui Peng; Ze-Bin Chen; Mimi Tang; Zhihang Chen; Yang Hou; Zhenwei Peng; Ming Kuang
Journal:  Eur Radiol       Date:  2019-01-28       Impact factor: 5.315

2.  Pre-operative Microvascular Invasion Prediction Using Multi-parametric Liver MRI Radiomics.

Authors:  Giacomo Nebbia; Qian Zhang; Dooman Arefan; Xinxiang Zhao; Shandong Wu
Journal:  J Digit Imaging       Date:  2020-12       Impact factor: 4.056

3.  Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.

Authors:  Gu-Wei Ji; Fei-Peng Zhu; Qing Xu; Ke Wang; Ming-Yu Wu; Wei-Wei Tang; Xiang-Cheng Li; Xue-Hao Wang
Journal:  Radiology       Date:  2020-01-14       Impact factor: 11.105

4.  The significance of classifying microvascular invasion in patients with hepatocellular carcinoma.

Authors:  Shuji Sumie; Osamu Nakashima; Koji Okuda; Ryoko Kuromatsu; Atsushi Kawaguchi; Masahito Nakano; Manabu Satani; Shingo Yamada; Shusuke Okamura; Maisa Hori; Tatsuyuki Kakuma; Takuji Torimura; Michio Sata
Journal:  Ann Surg Oncol       Date:  2013-11-20       Impact factor: 5.344

5.  Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.

Authors:  Yan-Ming Zhou; Lu Cao; Bin Li; Rui-Xiu Zhang; Cheng-Jun Sui; Zheng-Feng Yin; Jia-Mei Yang
Journal:  Ann Surg Oncol       Date:  2011-05-17       Impact factor: 5.344

6.  Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma.

Authors:  Xun Xu; Hai-Long Zhang; Qiu-Ping Liu; Shu-Wen Sun; Jing Zhang; Fei-Peng Zhu; Guang Yang; Xu Yan; Yu-Dong Zhang; Xi-Sheng Liu
Journal:  J Hepatol       Date:  2019-03-13       Impact factor: 25.083

7.  Anatomic versus nonanatomic resection in cirrhotic patients with early hepatocellular carcinoma.

Authors:  Alessandro Cucchetti; Guo-Liang Qiao; Matteo Cescon; Jun Li; Yong Xia; Giorgio Ercolani; Feng Shen; Antonio Daniele Pinna
Journal:  Surgery       Date:  2013-10-14       Impact factor: 3.982

8.  Biochemical and Clinical Predictive Approach and Time Point Analysis of Hepatobiliary Phase Liver Enhancement on Gd-EOB-DTPA-enhanced MR Images: A Multicenter Study.

Authors:  Masahiro Okada; Takamichi Murakami; Ryohei Kuwatsuru; Yuko Nakamura; Hiroyoshi Isoda; Satoshi Goshima; Ryota Hanaoka; Hiroki Haradome; Yoshinobu Shinagawa; Azusa Kitao; Yasunari Fujinaga; Nagaaki Marugami; Masako Yuki; Tomoaki Ichikawa; Atsushi Higaki; Masatoshi Hori; Shinya Fujii; Osamu Matsui
Journal:  Radiology       Date:  2016-05-19       Impact factor: 11.105

9.  Gene-expression phenotypes for vascular invasiveness of hepatocellular carcinomas.

Authors:  Shinji Tanaka; Kaoru Mogushi; Mahmut Yasen; Norio Noguchi; Atsushi Kudo; Noriaki Nakamura; Koji Ito; Yoshio Miki; Johji Inazawa; Hiroshi Tanaka; Shigeki Arii
Journal:  Surgery       Date:  2009-11-27       Impact factor: 3.982

10.  Overexpression of EMT-inducing transcription factors as a potential poor prognostic factor for hepatocellular carcinoma in Asian populations: A meta-analysis.

Authors:  Tao Wan; Tianwei Zhang; Xiaoying Si; Yanming Zhou
Journal:  Oncotarget       Date:  2017-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.